Results from the TRIUMPH-4 trial, published in December 2025, showed participants with obesity and knee osteoarthritis taking retatrutide 12mg lost an average of 28.7% of their body weight at 68 weeks
Among the 58% of adults who say they want to lose weight, nearly one-third (32%) expect to start a prescription GLP-1 drug in 2026, which translates to an estimated 48 million American adults including 9% who say they definitely will and 23% who say they probably will
It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you
Before long, the drugs were making the rounds for weight-loss alone
Edelman has written two books for patients and their physicians: Menopause Matters: Your Guide to a Long and Healthy Life (Johns Hopkins University Press) and Successful Sleep Strategies for Women (Harvard Health Publications)
Understanding Pharmacokinetics Deep dive into half-life, steady state, and drug level science.